TI Single Vector Distractor Body with Right Foot/20mm; Catalog ID 487.962 The Titanium Single ...
FDA Device Recall #Z-2581-2016 — Class II — May 23, 2016
Recall Summary
| Recall Number | Z-2581-2016 |
| Classification | Class II — Moderate risk |
| Date Initiated | May 23, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Synthes (USA) Products LLC |
| Location | West Chester, PA |
| Product Type | Devices |
| Quantity | 90 units |
Product Description
TI Single Vector Distractor Body with Right Foot/20mm; Catalog ID 487.962 The Titanium Single Vector Distractor and Proximal Foot Plates are intended for mandibular bone lengthening where gradual bone distraction is required, including conditions such as congenital mandibular deficiencies or post-traumatic defects.
Reason for Recall
DePuy Synthes is voluntarily initiating a recall due to a possibility the fastener on the Titanium Single Vector Distractor Body may become prematurely separated from the Proximal Foot Plate.
Distribution Pattern
Worldwide Distribution-US (nationwide) distribution to states of: AZ, CA, CO, DC, FL, IL, MA, MI, NJ, NY, PA, TX, UT, WI, and WV; and countries of: Australia, Canada and Switzerland.
Lot / Code Information
Part # 487.962, Lot # A4JY080; 4042146; 4042147; 4365410; 4548558; 4664392; 5041113; 5041114; 5041162; 5071337; 5229307; 5414447; 5414448; 5414449; 5422905; 5621082; 5621083; 5621088; 5696010; 6164423; 6164425; 6164555; 6171239; 6171240; 6397761; 7537258; 7927945, mfg date 09JUN1999 -30JUN2015, exp date 22MAR2020-30JUN2035
Other Recalls from Synthes (USA) Products LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0228-2026 | Class II | LOW PROF LCKNG SCREW, F/IM NAIL 5.0MM / L, 46MM... | Sep 26, 2025 |
| Z-0229-2026 | Class II | LOW PROF LCKNG SCREW, F/IM NAIL 5.0MM / L, 42MM... | Sep 26, 2025 |
| Z-1916-2024 | Class II | STARDRIVE SCRWDRVR SHFT/T4 50MM/SELF-RETAINING/... | Apr 25, 2024 |
| Z-1239-2024 | Class II | TFNA Femoral Nail 9mm, right, 130¿, L 235mm-In... | Jan 24, 2024 |
| Z-1238-2024 | Class II | RAPIDSORB IPS Battery Pack, Sterile-Intended fo... | Jan 24, 2024 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.